Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000485922 | SCV000573169 | pathogenic | not provided | 2021-12-07 | criteria provided, single submitter | clinical testing | Initiation codon variant in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV000688580 | SCV000816199 | uncertain significance | Progressive myoclonic epilepsy | 2021-12-08 | criteria provided, single submitter | clinical testing | This sequence change affects the initiator methionine of the CSTB mRNA. The next in-frame methionine is located at codon 2. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CSTB-related conditions. ClinVar contains an entry for this variant (Variation ID: 423466). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Athena Diagnostics | RCV000485922 | SCV002771371 | likely pathogenic | not provided | 2022-08-04 | criteria provided, single submitter | clinical testing | The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant disrupts the translation initiation codon and is predicted to interfere with protein translation. In multiple individuals, this variant has been seen with a single recessive pathogenic variant in the same gene, suggesting this variant may also be pathogenic. |
Mayo Clinic Laboratories, |
RCV000485922 | SCV004225547 | uncertain significance | not provided | 2023-05-24 | criteria provided, single submitter | clinical testing |